Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).
Figueiredo A, Almeida MA, Almodovar MT, Alves P, Araújo A, Araújo D, Barata F, Barradas L, Barroso A, Brito U, Camacho E, Canário D, Cardoso T, Chaves A, Costa L, Cunha J, Duarte J, Estevinho F, Felizardo M, Fernandes JP, Ferreira L, Ferreira L, Fidalgo P, Freitas C, Garrido P, Gil N, Hasmucrai D, Jesus E, Lopes JA, de Macedo JE, Meleiro A, Neveda R, Nogueira F, Pantorotto M, Parente B, Pego A, Rocha M, Roque J, Santos C, Saraiva J, Silva E, Silva S, Simões S, Soares M, Teixeira E, Timóteo T, Hespanhol V. Figueiredo A, et al. Among authors: barata f. Pulmonology. 2020 Jan-Feb;26(1):10-17. doi: 10.1016/j.pulmoe.2019.06.001. Epub 2019 Oct 18. Pulmonology. 2020. PMID: 31630986 Free article.
Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel.
Araújo A, Barroso A, Parente B, Travancinha C, Teixeira E, Martelo F, Fernandes G, Paupério G, Queiroga H, Duarte I, da Costa JD, Soares M, Borralho P, Costa P, Chinita P, Almodôvar T, Barata F. Araújo A, et al. Among authors: barata f. Pulmonology. 2024 Mar-Apr;30(2):159-169. doi: 10.1016/j.pulmoe.2022.11.008. Epub 2023 Jan 29. Pulmonology. 2024. PMID: 36717296 Free article. Review.
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut.
Barata F, Queiroga H, Teixeira E, Almodovar MT, Parente B, Soares M. Barata F, et al. Rev Port Pneumol (2006). 2016 Sep-Oct;22(5):287-8. doi: 10.1016/j.rppnen.2016.03.009. Epub 2016 May 6. Rev Port Pneumol (2006). 2016. PMID: 27162148 Free article. Clinical Trial. No abstract available.
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel.
Fernandes MGO, Vilariça AS, Fernandes B, Camacho C, Saraiva C, Estevinho F, Novais E Bastos H, Lopes JM, Fidalgo P, Garrido P, Alves S, Silva S, Sequeira T, Barata F. Fernandes MGO, et al. Among authors: barata f. Pulmonology. 2024 Jan-Feb;30(1):4-7. doi: 10.1016/j.pulmoe.2022.11.009. Epub 2023 May 18. Pulmonology. 2024. PMID: 37210340 Free article. No abstract available.
[Epidemiological study of lung cancer in Portugal (2000/2002)].
Parente B, Queiroga H, Teixeira E, Sotto-Mayor R, Barata F, Sousa A, Melo MJ, João F, Neveda R, Cunha J, Fernandes A, Manuel M, Cardoso T, Ferreira L, Nogueira F, Duarte J, Semedo E, Brito U, Pimentel F, Barros S, Costa F, Almodôvar T, Araújo A. Parente B, et al. Among authors: barata f. Rev Port Pneumol. 2007 Mar-Apr;13(2):255-65. Rev Port Pneumol. 2007. PMID: 17571453 Portuguese.
69 results